Commission Implementing Regulation (EU) 2017/2312 of 13 December 2017 concerning the authorisation of a new use of the preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for sows, suckling piglets and dogs (holder of the authorisation Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Joint committee decision (JCD)
079/2018 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2017/2312 of 13 December 2017 concerning the authorisation of a new use of the preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for sows, suckling piglets and dogs (holder of the authorisation Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office)
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2017/2312 frá 13. desember 2017 um leyfi fyrir nýrri notkun á blöndu með Bacillus subtilis C-3102 (DSM 15544) sem fóðuraukefni fyrir gyltur, mjólkurgrísi og hunda (leyfishafi er Asahi Calpis Wellness Co. Ltd, fulltrúi er Asahi Calpis Wellness Co. Ltd Europe Representative Office)
Durchführungsverordnung (EU) 2017/2312 der Kommission vom 13. Dezember 2017 zur Zulassung eines neuen Verwendungszwecks der Zubereitung aus Bacillus subtilis C-3102 (DSM 15544) als Zusatzstoff in Futtermitteln für Sauen, Saugferkel und Hunde (Zulassungsinhaber: Asahi Calpis Wellness Co. Ltd, vertreten durch Asahi Calpis Wellness Co. Ltd Europe Representative Office)
Kommisjonens gjennomføringsforordning (EU) 2017/2312 av 13. desember 2017 om godkjenning av ny bruk av preparatet av Bacillus subtilis C-3102 (DSM 15544) som tilsetningsstoff i fôrvarer for purker, spedgriser og hunder (innehaver av godkjenningen: Asahi Calpis Wellness Co. Ltd, representert ved Asahi Calpis Wellness Co. Ltd Europe Representative Office)
History
28.04.2018
Adopted JCD confirmed entry into force date
28.04.2018
Compliance date in the EEA
27.04.2018
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
02.03.2018
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
13.12.2017
Adoption date in the EU
02.01.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.